These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2323346)
1. Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration. Lange KW Eur J Pharmacol; 1990 Jan; 175(1):57-61. PubMed ID: 2323346 [TBL] [Abstract][Full Text] [Related]
2. Circling behavior in old rats after unilateral intranigral injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Lange KW Life Sci; 1989; 45(18):1709-14. PubMed ID: 2531261 [TBL] [Abstract][Full Text] [Related]
3. Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+). Lange KW J Toxicol Clin Exp; 1989; 9(1):21-5. PubMed ID: 2787400 [TBL] [Abstract][Full Text] [Related]
4. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+. Sun CJ; Johannessen JN; Gessner W; Namura I; Singhaniyom W; Brossi A; Chiueh CC J Neural Transm; 1988; 74(2):75-86. PubMed ID: 3266233 [TBL] [Abstract][Full Text] [Related]
6. Unilateral intranigral injection of MPTP in the rat induces contraversive turning. Welzl H; Lange KW Eur J Pharmacol; 1986 Dec; 132(2-3):295-7. PubMed ID: 3493164 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity. Lin AM; Yang CH; Ueng YF; Luh TY; Liu TY; Lay YP; Ho LT Neurochem Int; 2004 Jan; 44(2):99-105. PubMed ID: 12971912 [TBL] [Abstract][Full Text] [Related]
8. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra. Sayre LM; Arora PK; Iacofano LA; Harik SI Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462 [TBL] [Abstract][Full Text] [Related]
9. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices. Kurstjens NP; Cantrill RC Eur J Pharmacol; 1989 Oct; 169(1):147-52. PubMed ID: 2574687 [TBL] [Abstract][Full Text] [Related]
10. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. Sonsalla PK; Zeevalk GD; Manzino L; Giovanni A; Nicklas WJ J Neurochem; 1992 May; 58(5):1979-982. PubMed ID: 1560247 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
12. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat. Kelly E; Jenner P; Marsden CD Exp Brain Res; 1984; 55(2):243-52. PubMed ID: 6611272 [TBL] [Abstract][Full Text] [Related]
13. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
14. Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodents. Melamed E; Soffer D; Rosenthal J; Pikarsky E; Reches A Neurosci Lett; 1987 Dec; 83(1-2):41-6. PubMed ID: 3502019 [TBL] [Abstract][Full Text] [Related]
15. The effect of prenatal treatment with MPTP or MPP+ on the development of dopamine-mediated behaviors in rats. Weissman EM; Norman AB; Calderon SF; Zubrycki EM; el-Etri MM; Shipley MT; Sanberg PR Pharmacol Biochem Behav; 1989 Nov; 34(3):545-51. PubMed ID: 2623012 [TBL] [Abstract][Full Text] [Related]
16. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542 [TBL] [Abstract][Full Text] [Related]
17. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus. Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315 [TBL] [Abstract][Full Text] [Related]
18. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. Lau YS; Fung YK Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026 [TBL] [Abstract][Full Text] [Related]
20. Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats. Perry JC; Da Cunha C; Anselmo-Franci J; Andreatini R; Miyoshi E; Tufik S; Vital MA Eur J Pharmacol; 2004 Jan; 484(2-3):225-33. PubMed ID: 14744607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]